The Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines (https://cpicpgx.org/guidelines/) for SLCO1B1 and simvastatin-induced myopathy were used to assign the likely OATP1B1 phenotypes: normal function, decreased function, poor function, increased function, indeterminate function and *allele nomenclature [10]. This evidence concerns the gene SLCO1B1 and myopathy.